Glioblastoma trial design is expanding and becoming more suited to clinical practice
Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...
US News Live Today March 25, 2025: What is glioblastoma, aggressive brain cancer that ...
Stay informed with real-time updates on all major events in the United States. From breaking news to in-depth stories, we ...
When it comes to funding for novel drugs and devices, waiting for a government decision is ...
A promising treatment to extend the lives of glioblastoma patients is waiting on the worst form of bureaucracy ...
Suppressing key protein may unlock immunotherapy for glioblastoma
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...
People4 年
6-Year Glioblastoma Survivor Reflects on His Rare Journey: 'I Live Life to the Fullest'
Greg Link was diagnosed with glioblastoma in June 2014 and has since surpassed the typical life expectancy of a majority of patients Jason Hahn is a former Human Interest and Sports Reporter for ...
Suppressing a Single Protein Sparks New Hope for Brain Cancer
Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...
EurekAlert!9 天
Study: suppressing key protein may unlock immunotherapy for Glioblastoma
Glioblastoma has remained one of the toughest cancers to treat, but new research suggests that suppressing a protein (ZNF638) ...
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...